Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Th. Büchner"'
Autor:
Wolfgang E. Berdel, Dennis Görlich, Tim Sauer, Th. Büchner, Carsten Müller-Tidow, Georg Lenz, Christoph Schliemann, Michele Pohlen, M Stelljes, Christoph Groth, Rolf M. Mesters
Publikováno v:
Bone Marrow Transplantation. 51:1441-1448
Allogeneic stem cell transplantation (SCT) remains the best curative option for patients with refractory AML or with high-risk myelodysplastic syndrome (MDS). For decades, age alone had been widely used as the primary criterion to assess eligibility
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f605df141f5e942a9cd9d26d18feb4dc
https://doi.org/10.1038/bmt.2016.156
https://doi.org/10.1038/bmt.2016.156
Autor:
Carsten Müller-Tidow, Gerda Silling, Rolf M. Mesters, Christoph Groth, Torsten Kessler, Jörn C. Albring, Dennis Görlich, M Stelljes, Wolfgang E. Berdel, R Besoke, Th. Büchner, Tim Sauer, Felix Rosenow, Utz Krug, Georg Evers
Publikováno v:
Bone Marrow Transplantation. 50:485-492
Non-relapse mortality after Allo-SCT has significantly decreased over the last years. Nevertheless, relapse remains a major cause for post SCT mortality in patients with AML and high-risk myelodysplastic syndrome (MDS). In this retrospective single-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7671a8e16cb955dc590303626f7e00da
https://doi.org/10.1038/bmt.2014.300
https://doi.org/10.1038/bmt.2014.300
Autor:
Xaver Schiel, M. Unterhalt, Dietrich W. Beelen, Bernhard Wörmann, Th. Büchner, Karsten Spiekermann, Peter Staib, Hubert Serve, Achim Heinecke, Michael Fiegl, Wolfgang E. Berdel, Wolfgang Kern, Marcus Hentrich, Cristina Sauerland, D Schöndube, Andreas Grüneisen, Albrecht Reichle, C Rieger, Wolfgang Hiddemann, Jan Braess
Publikováno v:
Leukemia. 28:1001-1007
Chemomodulation of cytarabine by fludarabine has been attributed with a higher antileukemic efficacy, but randomized trials to address this question are rare. We therefore conducted a multicenter, randomized phase III study to evaluate the antileukem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4510adb2d754e3db3eb8d387da7c24f5
https://doi.org/10.1038/leu.2013.297
https://doi.org/10.1038/leu.2013.297
Autor:
R Peter Gale, Torsten Haferlach, Peter Staib, Eva Lengfelder, Rolf M. Mesters, Wolfgang E. Berdel, Aristoteles Giagounidis, Utz Krug, Ruediger Hehlmann, Th. Büchner, A. Reichle, K. Spiekermann, Hubert Serve, Leopold Balleisen, Bernhard Wörmann, Andreas Grüneisen, Dennis Görlich, M Stelljes, Jan Braess, Maria-Cristina Sauerland, Andreas Faldum, Wolfgang Hiddemann, Wolfgang Köpcke, Susanne Schnittger, Hartmut Eimermacher, Carsten Müller-Tidow, Herbert Rasche, Achim Heinecke, Claudia Haferlach
Publikováno v:
Leukemia. 30(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ae168f5a603a655685f3386b6f6342
https://pubmed.ncbi.nlm.nih.gov/27282253
https://pubmed.ncbi.nlm.nih.gov/27282253
Autor:
Georg Maschmeyer, W.-D. Ludwig, Hubert Serve, Leopold Balleisen, Peter Staib, Wolfgang E. Berdel, Christoph Schliemann, Karsten Spiekermann, Eckhard Thiel, Bernhard Wörmann, Th. Büchner, M Stelljes, Dennis Görlich, Carsten Müller-Tidow, Wolfgang Köpcke, Achim Heinecke, Susanne Schnittger, Aristoteles Giagounidis, Claudia Haferlach, Jan Braess, Andreas Grüneisen, Maria-Cristina Sauerland, Hartmut Eimermacher, Herbert Rasche, Wolfgang Kern, Robert Peter Gale, Wolfgang Hiddemann, Dietrich W. Beelen, A. Reichle, Carlo Aul, Ruediger Hehlmann, Utz Krug, Torsten Haferlach, Eva Lengfelder
Publikováno v:
Leukemia. 30(6)
We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive chemotherapies assigned at study-entry and analyzed on an intent-to-treat basis improved outcomes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b98df8f7d90f012652ff0d6fdf4d7f2
https://pubmed.ncbi.nlm.nih.gov/26859081
https://pubmed.ncbi.nlm.nih.gov/26859081
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 114:599-605
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d18edc2d412cc01dd982190d7b21ef0
https://doi.org/10.1055/s-2008-1066643
https://doi.org/10.1055/s-2008-1066643
Autor:
Th. Büchner, Ruediger Liersch, Ralf Bieker, Nils H. Thoennissen, Torsten Kessler, Joachim Gerss, Wolfgang E. Berdel, Christoph Schliemann, Rolf M. Mesters
Publikováno v:
Leukemia. 21:1901-1906
Angiogenesis plays an important role in solid tumors and hematologic malignancies. The angiopoietins act as essential regulators in this process. We investigated the impact of circulating angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2) and soluble Tie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af3a913bcf79b890c99b6e3ddf00904c
https://doi.org/10.1038/sj.leu.2404820
https://doi.org/10.1038/sj.leu.2404820
Autor:
Thomas Köhnke, Annika Dufour, Th. Büchner, Max Hubmann, Marion Subklewe, Laubender Rp, Maria-Cristina Sauerland, Stephanie Schneider, Jan Braess, Eva Hoster, Katharina Ringel, Wolfgang E. Berdel, Stefan K. Bohlander, Daniela Sauter, Karsten Spiekermann, Purvi M. Kakadia, Wolfgang Hiddemann, Bernhard Wörmann
Publikováno v:
Leukemia 29, 377-386 (2015)
In acute myeloid leukemia (AML), assessment of minimal residual disease (MRD) by flow cytometry (flow MRD) after induction and consolidation therapy has been shown to provide independent prognostic information. However, data on the value of earlier f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678ddd248894923455515111f4069e05
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=31596
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=31596
Autor:
B. Wörmann, Michaela Feuring-Buske, Karsten Spiekermann, Achim Heinecke, Christian Buske, Claudia Schoch, Wolfgang Kern, Jan Braess, T Haferlach, Cristina Sauerland, Th. Büchner, Wolfgang E. Berdel, Susanne Schnittger, Wolfgang Hiddemann
Publikováno v:
Critical Reviews in Oncology/Hematology. 56:235-245
Genetic and molecular techniques have provided increasing insights into the biology of acute myeloid leukemia (AML). These investigations showed that AML is not a homogeneous disease but a heterogeneous group of biologically different subentities. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::058f8fd32ed6d0f57b0a2b00a4b157af
https://doi.org/10.1016/j.critrevonc.2005.07.004
https://doi.org/10.1016/j.critrevonc.2005.07.004
Autor:
Carsten Müller-Tidow, Packeisen J, Th. Büchner, Arnold Ganser, K. Kügler, Horst Buerger, W.-D. Ludwig, Wolfgang E. Berdel, Achim Heinecke, Metzelder Sk, Adigüzel G, Hubert Serve, Joachim Schwäble, Gerhard Heil, Björn Steffen
Publikováno v:
Leukemia. 18:720-726
Cell cycle aberrations are associated with therapy outcome in many types of cancer. We analyzed mRNA expression levels of 18 cell cycle-related genes in bone marrow samples from 78 acute myeloid leukemia (AML) patients and six controls using high-thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbaf0172abe0a934598bee64a8a3229e
https://doi.org/10.1038/sj.leu.2403296
https://doi.org/10.1038/sj.leu.2403296